Cost-effectiveness analysis of serplulimab in combination with cisplatin plus 5-fluorouracil chemotherapy compared to cisplatin plus 5-fluorouracil chemotherapy as first-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China

BACKGROUND: This study evaluated the cost-effectiveness of serplulimab plus chemotherapy versus chemotherapy alone in treating advanced/metastatic esophageal squamous cell carcinoma (ESCC) within the Chinese health care system. METHODS: A partitioned survival model based on ASTRUM-007 trial patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying-Tao, Zhou, Chong-Chong, Xu, Kai, Zhang, Meng-Die, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666699/
https://www.ncbi.nlm.nih.gov/pubmed/38028139
http://dx.doi.org/10.1177/17588359231213621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666699/
https://www.ncbi.nlm.nih.gov/pubmed/38028139
http://dx.doi.org/10.1177/17588359231213621

Ejemplares similares